Examkin

Soru

Zorluk: OrtaDepressive Disorders

Accompanied by his roommate, a 21-year-old male college student is brought to the university counseling and psychiatric emergency center. Three weeks ago, he was evaluated at a local walk-in clinic for a two-month history of profound low mood, sleeping up to 14 hours a day, intense cravings for sugary foods, and a sensation that his arms were excessively heavy. At that time, he was diagnosed with major depressive disorder and prescribed fluoxetine. Today, the roommate reports a drastic change in the patient's behavior over the past four days. The patient is currently pacing the examination room, speaking rapidly, and excitedly explaining that he has discovered a theoretical formula that will solve global energy shortages. He mentions he has only slept for two hours over the past two days but feels 'more energetic than ever.' Medical history is otherwise unremarkable. Vital signs are within normal limits. Which of the following is the most appropriate next step in the management of this patient?

  1. A
    Increase the dosage of the current antidepressant to adequately treat agitated depression
  2. B
    Continue the current antidepressant and add a monoamine oxidase inhibitor to target atypical features
  3. Discontinue the current medication and initiate a mood-stabilizing atypical antipsychoticCevap
  4. D
    Admit the patient and diagnose schizophreniform disorder due to the presence of grandiose delusions
  5. E
    Initiate disciplinary action against the previous provider for failing to screen for bipolar disorder prior to prescribing

Cevap

Discontinue the current medication and initiate a mood-stabilizing atypical antipsychotic
This patient is presenting with an acute manic episode, characterized by a decreased need for sleep, pressured speech, psychomotor agitation, and grandiose delusions. This episode was likely precipitated by the initiation of fluoxetine. The patient's initial presentation of atypical depression (hypersomnia, hyperphagia, leaden paralysis) carries a higher risk of underlying bipolarity. The most appropriate immediate step in management is to discontinue the offending antidepressant, which is fueling the mania, and simultaneously initiate an antimanic medication, such as a mood-stabilizing atypical antipsychotic (e.g., quetiapine, olanzapine) to rapidly control the acute symptoms.

Adım Adım Çözüm

1
Analyze the patient's initial presentation and current symptoms.
The patient initially presented with symptoms of atypical depression and was prescribed an SSRI. He now presents with a decreased need for sleep, pressured speech, pacing, and grandiose delusions.
Establishing a clinical timeline is necessary to determine the cause of the sudden behavioral change.
2
Identify the new clinical syndrome.
The patient is experiencing an acute manic episode, likely antidepressant-induced.
SSRI monotherapy in patients with unrecognized bipolar disorder (often presenting initially with atypical features) can trigger a manic switch.
3
Determine the most appropriate next step in management.
The offending SSRI must be discontinued, and an antimanic agent should be initiated.
Continuing the precipitating agent worsens mania, and acute mania requires immediate pharmacologic intervention.

Anahtar Kavram

Patients presenting with atypical depression are at a higher risk for underlying bipolar disorder. Initiation of an SSRI without a mood stabilizer in these patients can precipitate an acute manic episode, which requires immediate discontinuation of the antidepressant and initiation of an antimanic agent.
Bu soruyu puanla

Konular

Depressive Disorders

Bu konudan daha fazla soru